Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

The testes significantly contribute to vitamin D metabolism and may affect male reproductive health and conditions like hair loss.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Hair diameter diversity helps assess hair loss, but its standard measure varies by individual and ethnicity.

The new AI system accurately diagnoses hair disorders and offers personalized treatment recommendations.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

New methods for measuring dutasteride are effective and reliable.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Hair transplant assistants in the UK must follow certain behavior and quality rules.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Dihydrotestosterone (DHT) promotes the growth and spread of aggressive brain tumor cells.

Dutasteride is approved to help manage prostate enlargement.

Certain Dibenzo derivatives may help treat prostate cancer.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.